Mobile Apps in Oncology: A Survey on Health Care Professionals' Attitude Toward Telemedicine, mHealth, and Oncological Apps.

Kerstin Anne Kessel Marco M E Vogel Friederike Schmidt-Graf Stephanie E Combs

Published in: Journal of medical Internet research (2016)

A majority of HCPs are in favor of telemedicine and the use of oncological apps by patients. Assessing side effects can lead to quicker response and thus lower inconvenience for patients. Clinical data, such as life quality and treatment satisfaction, could be used to evaluate and improve the therapy workflow. Eventually, a mobile app would enhance the patients' relationship to their treating department because they are in permanent contact.

Keyphrases

end stage renal disease
ejection fraction
healthcare
newly diagnosed
chronic kidney disease
palliative care
stem cells
bone marrow
electronic health record
deep learning
mesenchymal stem cells
tertiary care
big data
social media
radical prostatectomy
artificial intelligence
combination therapy